Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis

Details for Australian Patent Application No. 2005259992 (hide)

Owner MedImmune, Inc.

Inventors Wu, Herren; Damschroder, Melissa; Dall'Acqua, William

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005259992

PCT Pub. Number WO2006/004663

Priority 60/583,184 25.06.04 US; 60/624,153 02.11.04 US

Filing date 24 June 2005

Wipo publication date 12 January 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/004663 Priority application(s): WO2006/004663

9 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259998-Improved synthesis of 6-alkyl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds

2005259991-Compositions and methods for treating neurological disorders